Business Wire

Heart Center Dresden to Be First Commercial Clinical Site for Imricor

Del

Imricor announced today that it signed its first commercialization contract for the Advantage-MR EP Recorder/Stimulator System and supporting Vision-MR devices1 with the Heart Center Dresden in Germany. This agreement places the Heart Center Dresden at the forefront of clinical advancement for MRI-guided cardiac ablations and establishes the hospital as a world leader in the growing field of interventional cardiac magnetic resonance (iCMR).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181010005779/en/

Dr. Christopher Piorkowski in the newly installed iCMR lab at the Heart Center Dresden. (Photo: Hear ...

Dr. Christopher Piorkowski in the newly installed iCMR lab at the Heart Center Dresden. (Photo: Heart Center Dresden)

“Here at the Heart Center Dresden, we are proud to have the opportunity and the commitment to pioneer forefront research in the field of cardiac arrhythmia treatment,” said Dr. Christopher Piorkowski, Head of Electrophysiology at the Heart Center Dresden. “Having recently completed the successful installation of one of the most advanced cardiac MRI setups in the world, we are now preparing for the first routine clinical applications of catheter ablation within the MRI. We expect groundbreaking new insights and an innovative push into our understanding and treatment of patients with structural heart disease and related cardiac arrhythmias.”

Imricor’s Advantage-MR System and Vision-MR devices are state-of-the-art cardiac ablation tools that allow physicians to perform procedures under real-time MRI guidance. Unlike conventional x-ray guided procedures, ablations guided by MRI allow physicians to individualize the treatment strategy for each patient’s unique cardiac structure and substrate as well as assess lesion quality and fill gaps in ablation lines during the initial procedure. These benefits have the potential to improve patient outcomes and provide safer, more cost-effective treatment – all in an environment that is free of radiation for both the patient and physician.

Prof. Dr. Bärbel Held, Managing Director of the Heart Center Dresden, commented, “I am very proud, together with Imricor and Dr. Piorkowski, for the heart center in Dresden to introduce and apply such an innovation. For our patients, this will be a big advantage in the treatment of cardiac arrhythmias. This is what the Heart Center Dresden stands for.”

“This is an exciting milestone for both Imricor and the Heart Center Dresden. It marks the beginning of the commercial clinical application of iCMR-guided ablations and a new age for interventional cardiology,” said Steve Wedan, CEO of Imricor. “Prof. Held has a brilliant vision for the future of medicine at Heart Center Dresden, and we couldn’t be more thrilled to be working with Dr. Piorkowski and his extraordinary team as we usher in this new age together.”

1Delivery of Vision-MR devices will commence upon CE mark approval of devices.

About Imricor

Imricor Medical Systems is a privately held company committed to unlocking the potential of interventional cardiac magnetic resonance (iCMR) by delivering MR-compatible systems and devices that allow physicians to perform cardiac ablations under real-time MRI-guidance.

About the Heart Center Dresden

The Heart Center Dresden is a University Hospital owned by the Sana Kliniken AG. The Heart Center is structured into three departments – Cardiac Surgery, Cardiology, and Electrophysiology. Over 650 employees provide in-patient and out-patient services for nearly 25,000 patients per year. In alliance with the Technical University Dresden, medical education as well as research and sciences are integral parts of the portfolio.

CAUTION: The Advantage-MR™ EP Recorder/Stimulator System has received CE mark approval; it has not yet been approved for use in the United States. The Vision-MR™ Ablation Catheter has been approved as an investigational device for clinical studies in Europe. All other Imricor devices are not yet approved for use in humans.

Contact information

Imricor
Jodi Lamberti, +1 952-818-8417
info@imricor.com
www.imricor.com
or
Heart Center Dresden
Robert Reuther, +49 351 450 1555
robert.reuther@herzzentrum-dresden.com
www.herzzentrum-dresden.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Cred Opens Its Platform to Developers and Businesses10.12.2018 20:21Pressemelding

Cred, the leading provider of crypto-backed lending with over $300 million in credit facilities, today announced the launch of CredX, Cred’s developer platform, enabling any company or developer to turn their products into powerful financial applications for their customers. Crypto exchanges, crypto wallets, miner service providers, even traditional financial institutions have the ability to access Crypto Lending as a Service (CLaaS™) and create a rich set of customer experiences for their customers. “Lending and Earning Crypto are hard businesses to get right, particularly in a bear market,” said Dan Schatt, Co-Founder of Cred and the Universal Protocol Alliance. “A crypto custodian, wallet, merchant or exchange business can now offer their customers compelling credit and treasury management features built directly into their own apps, powered by Cred. Businesses can choose to use their own balance sheets, or leverage Cred’s to provide credit and earning services to generate revenue,

Axonics® Announces Publication of NICE Briefing10.12.2018 16:03Pressemelding

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, announced today the publication of a Medtech Innovation Briefing by The National Institute for Health and Care Excellence (“NICE”) following a careful review of the innovations offered by the Axonics System. The NICE Medtech Innovation Briefing entitled: “Axonics rechargeable sacral neuromodulation system for overactive bladder and faecal incontinence,” describes published clinical evidence on the Axonics r-SNM System®, confirming efficacy as well as the potential positive economic impact that is possible by the use of the Axonics system in the United Kingdom. The Axonics r-SNM System is the first rechargeable Sacral Neuromodulation system approved for sale in Europe and commercially available to all hospitals and clinics in the U.K. for patients

The Largest Blockchain Conference in Asia to Be Held 30–31 January in Yokohama, Japan10.12.2018 15:00Pressemelding

The Global Blockchain Association (Shimizu Building 6F, 3-19 Hayabusacho, Chiyoda-ku, Tokyo, President: Toshikazu Masuyama) is proud to host the largest blockchain conference in Asia: The Japan Blockchain Conference (JBC) – 2019 Yokohama, to be held on 30 and 31 January at Pacifico Yokohama. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181210005057/en/ The Japan Blockchain Conference (JBC) - 2019 Yokohama (Graphic: Business Wire) The conference will host top companies and organizations from Japan and abroad who represent the future of the rapidly growing blockchain space. This is the place where the leaders of blockchain and crypto can interact, form partnerships, and showcase their leading technologies and developments. We are actively looking for companies to join the best of the blockchain industry and exhibit at our conference. More details can be found here: http://japan-blockchain-c.com/en/ We welcome a wide range of

Global Payments’ TouchNet Business Named “Partner of the Year” by Ellucian10.12.2018 13:30Pressemelding

Global Payments Inc. (NYSE: GPN), a leading worldwide provider of payment technology and software solutions is pleased to announce that its TouchNet business was named “Partner of the Year” by Ellucian, a provider of software and services that power higher education, at its Partner Forum reception during the annual EDUCAUSE Conference this year in Denver, CO. TouchNet was recognized for its collaborative efforts to deliver streamlined engaging, cloud-based, student commerce and credential solutions. This honor further demonstrates the depth and breadth of the TouchNet platform and its dedication to delivering software-driven and technology-enabled strategies to institutions of higher education. “TouchNet’s commitment to delivering maximum value enables Ellucian to consistently provide customers with best-in-class solutions, support and service,” said Chris Westfall, Vice President Partnerships Ellucian. “When you combine Ellucian’s feature rich technology and in-depth customer knowledg

CTS Engines Hires Tom Bode as Senior Vice President, Operations10.12.2018 13:00Pressemelding

CTS Engines, the global leader for mature engine maintenance within the Aerospace & Defense industry, announced today that it had hired Tom Bode as its Senior Vice President, Operations. In his new role, Mr. Bode will be responsible for all operations, quality, and engineering functions, and will report to Vesa Paukkeri, CTS Engines’s President and COO. Since 2008, Mr. Bode has been the General Manager of the Columbus Engine Center for Pratt & Whitney, a company he joined in 2000. Prior to 2000, Mr. Bode worked at GE Aviation, where he was a quality and engineering leader. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181210005036/en/ Tom Bode (Photo: Business Wire) “As the General Manager of CEC, Tom managed over 700 employees across multiple engine production lines and reduced overhaul turnaround times through the promotion of Lean manufacturing principles,” said Mr. Paukkeri. “His performance as a manager was recognized

Tracxpoint Signed a Major Agreement to Deploy its Artificial Intelligence Cart (AiC®) Platform at CONAD, One of the Largest and Most Sophisticated Supermarket Chains in Italy with 3,000 Locations in Lieu of Amazon Go after Intensive Study10.12.2018 11:00Pressemelding

Tracxpoint, a global provider of next-generation self-checkout grocery solutions, today announced an agreement to roll out its Artificial Intelligence Cart (AiC®) at CONAD DEL TIRRENO, one of the seven cooperatives of CONAD’s chain with more than 3,000 supermarket stores in Italy. This is a major milestone for the Israeli startup in its mission to establish the AiC® platform as the most powerful, accessible and comprehensive solution for self-checkout and personalized in-store engagement on the market today. CONAD DEL TIRRENO will start implementing the AiC® ecosystem during 2019. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181210005176/en/ The Tracxpoint AiC enables checkout-free stores and personalized in-store engagement for Italy's largest supermarket chain, CONAD. (Photo: Business Wire) In direct contrast to capital-intensive and smaller store concepts like Amazon Go or its imitators that rely on ceiling cameras for